Together with SPSE, EmulTech provides insight in the particle formation characteristics after droplet formation. This is done through the analysis of a single droplet in the research facilities of the Danish University.
Together with the University of Antwerp, EmulTech offers formulation analysis studies, such as release studies and particle characteristic analysis.
Together with SEPS Pharma, EmulTech offers microparticle formulation services. SEPS Pharma was the first CRO to use the INFINITY in its micro particle formulation work.
Together with Flowid, EmulTech continually develops and improves the INFINITY platform, both in the research phase as towards market relevant scale.